Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions world-wide, including Japan, the U... Show more
Nomura Holdings, Inc. (NMR) is a leading Japanese financial services firm offering a broad range of products including retail brokerage, wealth management, investment banking, wholesale services, and asset management to individual, corporate, and institutional clients globally. Headquartered in Tokyo, Nomura operates through three main segments: Retail, Wholesale, and Merchant Banking, with significant exposure to global markets, particularly in Asia, Europe, and the U.S. Its business model relies on fee-based revenues from advisory, underwriting, trading, and asset management, alongside net interest income (NII, earnings from lending minus funding costs). In a competitive landscape dominated by global giants like JPMorgan and Goldman Sachs, Nomura differentiates through its strong Asian footprint and wealth management growth, which has bolstered fundamentals amid recent stock price movements tied to trading volatility and earnings cycles.
Over the last 30 days, NMR stock moved from a close of $8.00 on March 25 to $7.87 on April 24, marking a -1.6% decline. The period was volatile and range-bound, dipping to $7.58 in late March before rallying to $8.75 mid-April, then falling sharply.
In the past quarter, shares dropped -13.0% from $9.04 on January 26 to the current $7.87, after peaking at $9.58 in mid-February. The trend was downward overall, with steady declines in March punctuated by an April rebound that faded recently, reflecting trend-driven corrections amid elevated volume during swings.
NMR's 30-day price movement stemmed primarily from earnings anticipation and company-specific actions amid financial sector volatility. Shares bottomed near $7.40 in mid-March before climbing on April 14 news of a substantial share buyback and cancellation program, tightening the equity base and signaling confidence. This propelled a rally to $8.75 by April 16. However, momentum stalled as investors awaited Q4 results, released April 24, which revealed a 19% Q4 net income drop to ¥73.9 billion despite 27% YoY revenue growth to ¥577.2 billion, due to higher expenses and impairments—triggering today's decline. Analyst sentiment remained mixed, with no major upgrades, while broader yen strength pressured trading desks.
The quarterly downturn reflected sustained pressures from earlier profit warnings and macroeconomic headwinds. Post-Q3 earnings in late January (EPS $0.20 miss), shares rallied to a February peak before dropping on disclosed crypto-related losses and European trading setbacks. March saw further weakness amid Japan financial sector trends, including BOJ rate hike impacts on NII and global equity selloffs. Institutional flows shifted cautiously, with Nomura's wholesale segment facing competition. Cumulative effects included volatile trading revenues sensitive to market trends, though record full-year results (net income up 6% to ¥362.1 billion, ROE (return on equity) at 10.1%) provided some support via wealth management strength.
Tickeron’s Trending AI Robots page showcases the platform's top-performing AI-driven trading bots from a library of hundreds scanning thousands of tickers like NMR. These bots employ diverse strategies—such as momentum, mean reversion, or pattern recognition—across various timeframes, from intraday to long-term swings. Performance metrics highlight win rates, average returns, and drawdowns, with only the most relevant and consistently strong bots featured based on recent market conditions. This curated selection helps traders identify tools aligned with current stock analysis and price movements in financials. Explore the page to discover bots potentially suited for monitoring NMR's volatility and integrating into your trading toolkit.
Key factors for NMR include upcoming macroeconomic developments like Bank of Japan (BOJ) policy shifts, which could boost NII but pressure trading if yen appreciates further. Monitor global interest rates and equity volatility impacting wholesale revenues. Company catalysts encompass execution of the ongoing share repurchase, wealth management client inflows, and M&A (mergers and acquisitions) activity in investment banking. Risks involve regulatory scrutiny in international ops and impairment charges; positive triggers may arise from sustained record profitability trends. Track sector peers and institutional ownership for sentiment shifts.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where NMR advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 29, 2026. You may want to consider a long position or call options on NMR as a result. In of 80 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
NMR moved above its 50-day moving average on May 29, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for NMR crossed bullishly above the 50-day moving average on May 21, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 17 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 270 cases where NMR Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for NMR moved out of overbought territory on June 18, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 55 cases where NMR's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NMR declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
NMR broke above its upper Bollinger Band on June 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.147) is normal, around the industry mean (4.088). P/E Ratio (12.225) is within average values for comparable stocks, (48.335). NMR's Projected Growth (PEG Ratio) (0.815) is slightly lower than the industry average of (1.857). Dividend Yield (0.036) settles around the average of (0.035) among similar stocks. P/S Ratio (2.402) is also within normal values, averaging (32.208).
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. NMR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a holding company with interests in financial services
Industry InvestmentBanksBrokers